Drug Reaction with Eosinophilia and Systemic Symptoms after Daclizamub TherapyNeurol 91:e359-e363, Rauer,S.,et al, 2018
Alemtuzumab vs. Interferon Beta-1a in Early Multiple SclerosisNEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008